• CHELSEA THERAPEUTICS INTL LT Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY
    Assets
    Cash and Short Term Investments 62.71 M 15.90 M 3.17 M 10.98 M —
    Net Receivables 0.00 0.00 0.00 0.00 —
    Total Inventories 0.00 0.00 0.00 0.00 —
    Progress Payments & Others 0.00 0.00 0.00 0.00 —
    Prepaid Expenses 216,820.00 196,929.00 99,025.00 — —
    Other Current Assets 392,562.00 0.00 0.00 0.00 —
    Current Assets Total 63.11 M 16.11 M 3.37 M 11.08 M —
    Long Term Receivables 0.00 0.00 0.00 0.00 —
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 —
    Other Investments 0.00 0.00 0.00 0.00 —
    Property, Plant & Equipment Net 42,793.00 42,938.00 43,200.00 51,164.00 —
    Property, Plant & Equipment Gross 146,103.00 115,226.00 80,099.00 62,535.00 —
    Accumulated Depreciation 103,310.00 72,288.00 36,899.00 11,371.00 —
    Other Assets 13,461.00 13,461.00 13,461.00 13,461.00 —
    Deferred Charges — — — — —
    Tangible Other Assets 13,461.00 13,461.00 13,461.00 — —
    Intangible Other Assets — — — — —
    Total Assets 63.16 M 16.17 M 3.43 M 11.14 M —
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 —
    Accrued Payroll 567,268.00 409,955.00 245,273.00 218,540.00 —
    Income Taxes Payable 0.00 0.00 0.00 0.00 —
    Dividends Payable 0.00 0.00 0.00 0.00 —
    Other Current Liabilities 3.74 M 1.58 M 292,931.00 260,887.00 —
    Current Liabilities Total 5.20 M 2.03 M 1.04 M 599,576.00 —
    Long Term Debt 0.00 0.00 0.00 0.00 —
    Provision for Risks & Charges — — — — —
    Deferred Taxes — — — — —
    Deferred Income 0.00 0.00 0.00 0.00 —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 0.00 0.00 0.00 0.00 —
    Total Liabilities 5.20 M 2.03 M 1.04 M 599,576.00 —
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 —
    Minority Interest 0.00 0.00 0.00 0.00 —
    Preferred Stock 0.00 0.00 0.00 0.00 —
    Common Equity 57.97 M 14.14 M 2.38 M 10.54 M —
    Common Stock 2,992.00 1,971.00 1,238.00 1,191.00 —
    Capital Surplus 92.65 M 33.74 M 13.32 M 13.59 M —
    Revaluation Reserves 0.00 0.00 0.00 0.00 —
    Other Appropriated Reserves -31,996.00 — — — —
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings -34.69 M -19.60 M -10.93 M -3.02 M —
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 —
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 —
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 0.00 —
    Treasury Stock 0.00 0.00 0.00 0.00 —
    Total Liabilities & Shareholders Equity 63.16 M 16.17 M 3.43 M 11.14 M —
    Common Shares Outstanding 29.92 M 12.38 M 12.38 M 11.91 M —